Lupin Limited
About us | Our major therapeutic focus areas: Anti tb, cepholosporins (both orals and injectables), ace inhibitors, statins and prils. In each of these segments we are among the world's dominant players. We are in the process of establishing ourselves as a major global force in nsaid, cardiovascular drugs and nutritional supplements. Our manufacturing is integrated: Apart from api (pharmaceutical products), we also make and market api advance penultimates |
---|---|
Industry Focus | Pharmaceutical Chemicals |
Business Type | Manufacturer |
Products/Services | Intermediates, api and finished dosages in pharmaceuticals |
Our Markets | Worldwide |
No. of Employees | Above 1000 People |
Annual Sales Range(USD) | Above US$100 Million |